Featured/ NVO/ 07/29/2025 · 10:03 AM Novo Nordisk Lowers 2025 Outlook, Names New CEO Novo Nordisk cut its 2025 sales and profit forecast due to slower US Wegovy & Ozempic sales, hit by competition and compounded GLP-1s. Maziar Mike Doustdar is the new CEO.
